Biolase Return on Tangible Equity 2010-2023 | BIOL
Current and historical return on tangible equity values for Biolase (BIOL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Biolase Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2023-12-31 |
$-0.04B |
$-0.00B |
-1381.82% |
| 2023-09-30 |
$-0.03B |
$0.00B |
-742.86% |
| 2023-06-30 |
$-0.03B |
$0.00B |
-527.27% |
| 2023-03-31 |
$-0.03B |
$0.01B |
-324.32% |
| 2022-12-31 |
$-0.03B |
$0.00B |
-232.00% |
| 2022-09-30 |
$-0.02B |
$0.01B |
-137.14% |
| 2022-06-30 |
$-0.02B |
$0.02B |
-88.37% |
| 2022-03-31 |
$-0.01B |
$0.02B |
-57.73% |
| 2021-12-31 |
$-0.02B |
$0.02B |
-58.18% |
| 2021-09-30 |
$-0.02B |
$0.03B |
-71.58% |
| 2021-06-30 |
$-0.03B |
$0.03B |
-156.96% |
| 2021-03-31 |
$-0.04B |
$0.03B |
-297.87% |
| 2020-12-31 |
$-0.03B |
$0.01B |
-1133.33% |
| 2020-09-30 |
$-0.03B |
$0.01B |
-2133.33% |
| 2020-06-30 |
$-0.02B |
$-0.00B |
888.89% |
| 2020-03-31 |
$-0.02B |
$-0.00B |
1266.67% |
| 2019-12-31 |
$-0.02B |
$0.00B |
-3600.00% |
| 2019-09-30 |
$-0.02B |
$-0.00B |
-933.33% |
| 2019-06-30 |
$-0.02B |
$0.00B |
-323.08% |
| 2019-03-31 |
$-0.02B |
$0.00B |
-209.52% |
| 2018-12-31 |
$-0.02B |
$0.01B |
-146.67% |
| 2018-09-30 |
$-0.02B |
$0.01B |
-117.95% |
| 2018-06-30 |
$-0.02B |
$0.02B |
-110.84% |
| 2018-03-31 |
$-0.02B |
$0.02B |
-100.00% |
| 2017-12-31 |
$-0.02B |
$0.03B |
-103.70% |
| 2017-09-30 |
$-0.02B |
$0.02B |
-108.11% |
| 2017-06-30 |
$-0.02B |
$0.02B |
-91.14% |
| 2017-03-31 |
$-0.02B |
$0.02B |
-98.63% |
| 2016-12-31 |
$-0.02B |
$0.02B |
-93.51% |
| 2016-09-30 |
$-0.01B |
$0.02B |
-65.00% |
| 2016-06-30 |
$-0.02B |
$0.02B |
-75.00% |
| 2016-03-31 |
$-0.02B |
$0.02B |
-78.26% |
| 2015-12-31 |
$-0.02B |
$0.02B |
-71.03% |
| 2015-09-30 |
$-0.02B |
$0.02B |
-67.74% |
| 2015-06-30 |
$-0.02B |
$0.03B |
-69.72% |
| 2015-03-31 |
$-0.02B |
$0.03B |
-88.89% |
| 2014-12-31 |
$-0.02B |
$0.04B |
-135.85% |
| 2014-09-30 |
$-0.02B |
$0.01B |
-336.84% |
| 2014-06-30 |
$-0.02B |
$0.00B |
-400.00% |
| 2014-03-31 |
$-0.01B |
$0.01B |
-254.55% |
| 2013-12-31 |
$-0.01B |
$0.01B |
-218.18% |
| 2013-09-30 |
$-0.01B |
$0.01B |
-138.46% |
| 2013-06-30 |
$-0.01B |
$0.01B |
-88.89% |
| 2013-03-31 |
$-0.01B |
$0.01B |
-66.67% |
| 2012-12-31 |
$-0.00B |
$0.01B |
-48.48% |
| 2012-09-30 |
$-0.01B |
$0.01B |
-84.85% |
| 2012-06-30 |
$-0.01B |
$0.01B |
-75.68% |
| 2012-03-31 |
$-0.01B |
$0.01B |
-58.54% |
| 2011-12-31 |
$-0.01B |
$0.01B |
-60.61% |
| 2011-09-30 |
$-0.00B |
$0.01B |
-66.67% |
| 2011-06-30 |
$-0.01B |
$0.01B |
inf% |
| 2011-03-31 |
$-0.01B |
$0.00B |
188.24% |
| 2010-12-31 |
$-0.01B |
$-0.01B |
252.63% |
| 2010-09-30 |
$-0.01B |
$-0.01B |
650.00% |
| 2010-06-30 |
$-0.01B |
$-0.01B |
-720.00% |
| 2010-03-31 |
$-0.00B |
$-0.00B |
-85.71% |
| 2009-12-31 |
$-0.00B |
$0.01B |
-75.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.005B |
$0.049B |
|
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
|
